Cargando…

Clozapine point of care testing in acute psychiatry: A precision approach to treatment resistant psychosis

INTRODUCTION: Clozapine, the antipsychotic of choice for treatment-resistant schizophrenia, has a narrow therapeutic range and high interpatient variability in the dose-response relationship. Serum clozapine levels are essential both for therapeutic dosing and to monitor adherence. Use of venepunctu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boland, X., Dratcu, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475674/ http://dx.doi.org/10.1192/j.eurpsy.2021.1216

Ejemplares similares

Clozapine in the Time of COVID-19
por: Boland, Xavier, et al.
Publicado: (2020)

Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
por: Montgomery, Adam, et al.
Publicado: (2023)

COVID-19 and the emergence of inpatient tele-ward rounds
por: Boland, X., et al.
Publicado: (2022)

Clozapine in First Episode Psychosis: The best is delayed
por: Rodrigues, J. B., et al.
Publicado: (2023)

Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review
por: Ying, Jiangbo, et al.
Publicado: (2023)

Associations between polygenic loading, psychosis liability, and clozapine use
por: Luykx, J.
Publicado: (2023)

Clozapine in first episode psychosis – the experience of a Portuguese center
por: Soares Da Costa, I., et al.
Publicado: (2023)

Loxapine in patient with clozapine-resistant psychosis
por: Erley, Jennifer, et al.
Publicado: (2021)

Treatment resistant psychosis in children and adolescents and clozapine: Nuances
por: Pattnaik, Jigyansa Ipsita, et al.
Publicado: (2023)

Kraepelin, the unitary psychosis theory and the classification in psychiatry
por: Martínez Jambrina, J. J.
Publicado: (2023)

Clozapine for mitochondrial psychosis()
por: Finsterer, Josef, et al.
Publicado: (2017)

Treating Methamphetamine-Induced Resistant Psychosis with Clozapine
por: Seddigh, Ruohollah, et al.
Publicado: (2014)

Clozapine prescribing during follow-up of a first-episode psychosis cohort
por: Rowntree, R., et al.
Publicado: (2021)

Counting ECGs in acute psychiatry – The patients' price for junior doctors' rotations
por: Rogowska, Marianna, et al.
Publicado: (2021)

Clozapine use in drug induced psychosis in Parkinson´s disease: a case report and review of literature.
por: Sanz Giancola, A., et al.
Publicado: (2023)

Clozapine Efficacy in a Case of Severe Treatment-Resistant Postpartum Psychosis
por: Teodorescu, Andreea, et al.
Publicado: (2021)

Authors' reply — Clozapine for mitochondrial psychosis
por: Demily, Caroline, et al.
Publicado: (2017)

Clozapine cessation
por: Ktari, H., et al.
Publicado: (2022)

Ethnic inequalities in treatment with clozapine
por: Fonseca De Freitas, D., et al.
Publicado: (2022)

Lurasidone augmentation to clozapine in treatment resistant schizophrenia: A pilot study
por: Arienti, V., et al.
Publicado: (2023)

921. Acute HAV Infection in an Inpatient Psychiatry Unit
por: Weston, Gregory, et al.
Publicado: (2021)

PROPSY: a new strategy to implement precision psychiatry in France
por: Llorca, P. M.
Publicado: (2023)

Audit on clozapine dose and plasma level correlation for patients with chronic treatment-resistant psychosis
por: Macnamara, Olivia, et al.
Publicado: (2021)

S146. EFFECT OF CLOZAPINE ON REGIONAL CEREBRAL BLOOD FLOW IN TREATMENT-RESISTANT SCHIZOPHRENIA
por: Sendt, Kyra-Verena, et al.
Publicado: (2018)

Combined use of clozapine and cariprazine in treatment-resistant schizophrenia, is it a good choice?
por: Darriba, H. Becerra
Publicado: (2021)

Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome
por: Kammoun, I., et al.
Publicado: (2022)

Mrna vaccination under clozapine treatment
por: Argitis, P., et al.
Publicado: (2022)

Electroconvulsive therapy combined with clozapine in the management of ultra-resistant schizophrenia
por: Khouadja, S., et al.
Publicado: (2021)

Clozapine and urinary incontinence
por: Osca Oliver, A., et al.
Publicado: (2022)

Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
por: Aboueid, Lila, et al.
Publicado: (2016)

Development of point-of-care testing devices to improve clozapine prescribing habits and patient outcomes
por: Kalaria, Shamir N, et al.
Publicado: (2019)

T203. RELEVANT CLOZAPINE BLOOD LEVELS USING A POINT OF CARE TEST (POCT)
por: Kelly, Deanna, et al.
Publicado: (2020)

Intramuscular clozapine in the acute medical hospital: Experiences from a liaison psychiatry team
por: Gee, Siobhan, et al.
Publicado: (2021)

PM443. The ECT Augmenting Effects for Patients with Clozapine-Resistant Schizophrenia
por: Kim, Hye Sung, et al.
Publicado: (2016)

Electroconvulsive therapy in a patient with resistant paranoid schizophrenia treated with clozapine
por: Castelao-Almodóvar, S., et al.
Publicado: (2021)

Resistant schizophrenia in a patient with oculocutaneous albinism successfully treated with clozapine
por: Jelti, A., et al.
Publicado: (2022)

Augmentation strategies for treatment-refractory clozapine patients
por: Freudenreich, O.
Publicado: (2021)

Clozapine treatment during the COVID-19 pandemic
por: Dąbrowska, E., et al.
Publicado: (2021)

Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Monitoring sertraline and clozapine levels
por: Rodriguez Campos, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3dd10e7ofiso1mlo54o2hr8f04